Header Logo

Fatima Laher

Concepts (268)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
AIDS Vaccines
29
2024
150
8.200
Why?
HIV Infections
44
2024
4946
3.580
Why?
HIV-1
19
2024
1239
2.490
Why?
Pre-Exposure Prophylaxis
3
2021
171
1.810
Why?
Adult
38
2024
5664
1.250
Why?
Humans
56
2024
14077
1.230
Why?
Young Adult
30
2024
2357
1.200
Why?
South Africa
38
2023
7312
1.090
Why?
Female
42
2024
8751
1.080
Why?
Male
35
2024
6489
1.070
Why?
HIV Antibodies
11
2024
243
1.060
Why?
Altitude
1
2024
9
0.950
Why?
Fibrin Fibrinogen Degradation Products
1
2024
19
0.940
Why?
Anti-HIV Agents
4
2021
1275
0.900
Why?
Adolescent
24
2024
2858
0.900
Why?
Circumcision, Male
3
2019
97
0.850
Why?
Antibodies, Neutralizing
5
2023
285
0.850
Why?
Immunization, Secondary
4
2021
62
0.810
Why?
Immunoglobulin G
5
2024
220
0.790
Why?
Double-Blind Method
12
2024
263
0.770
Why?
Contraception Behavior
4
2011
54
0.770
Why?
Neutropenia
1
2021
9
0.750
Why?
Adverse Drug Reaction Reporting Systems
1
2021
8
0.750
Why?
CD4-Positive T-Lymphocytes
3
2021
145
0.720
Why?
Human Immunodeficiency Virus Proteins
1
2020
10
0.700
Why?
Condoms
5
2020
86
0.550
Why?
Sexual Behavior
8
2023
313
0.530
Why?
Adjuvants, Immunologic
4
2024
21
0.520
Why?
Polysorbates
4
2024
10
0.520
Why?
Squalene
4
2024
10
0.520
Why?
HIV Envelope Protein gp120
5
2024
104
0.490
Why?
Genitalia
1
2014
8
0.490
Why?
Mucous Membrane
1
2014
12
0.490
Why?
Cell Phone
3
2020
34
0.490
Why?
Risk Factors
6
2024
1431
0.490
Why?
Specimen Handling
1
2014
103
0.460
Why?
HIV Seropositivity
3
2023
263
0.430
Why?
Fertility
2
2011
22
0.420
Why?
Antiretroviral Therapy, Highly Active
7
2017
468
0.400
Why?
Immunogenicity, Vaccine
3
2024
91
0.400
Why?
Middle Aged
10
2024
3425
0.400
Why?
Infectious Disease Transmission, Vertical
2
2012
467
0.370
Why?
Menstruation
2
2011
10
0.370
Why?
Antibodies, Monoclonal
3
2021
137
0.370
Why?
Clinical Trials as Topic
5
2023
112
0.360
Why?
Vaccination
7
2020
347
0.360
Why?
Menstruation Disturbances
1
2010
7
0.350
Why?
Mothers
1
2012
190
0.350
Why?
Intention
2
2010
23
0.350
Why?
Patient Preference
1
2010
22
0.350
Why?
Genetic Vectors
7
2021
54
0.340
Why?
Pregnancy Complications, Infectious
2
2012
507
0.340
Why?
Antibody Formation
5
2020
61
0.340
Why?
Decision Making
1
2009
52
0.320
Why?
Anti-Retroviral Agents
2
2016
542
0.310
Why?
Healthy Volunteers
3
2024
18
0.310
Why?
Focus Groups
4
2020
180
0.300
Why?
Incidence
4
2022
655
0.270
Why?
Self Report
4
2020
111
0.270
Why?
Antibody-Dependent Cell Cytotoxicity
3
2021
36
0.260
Why?
Air Travel
1
2024
4
0.240
Why?
Oximetry
1
2024
6
0.240
Why?
Thrombelastography
1
2024
6
0.240
Why?
nef Gene Products, Human Immunodeficiency Virus
2
2014
6
0.240
Why?
von Willebrand Factor
1
2024
21
0.240
Why?
Anti-Bacterial Agents
2
2019
274
0.240
Why?
Alum Compounds
1
2024
1
0.240
Why?
gag Gene Products, Human Immunodeficiency Virus
2
2014
20
0.230
Why?
pol Gene Products, Human Immunodeficiency Virus
2
2014
29
0.230
Why?
Thrombosis
1
2024
47
0.230
Why?
Follow-Up Studies
3
2021
367
0.230
Why?
Data Accuracy
1
2023
9
0.220
Why?
Immunization, Passive
2
2020
17
0.210
Why?
Adenoviridae
4
2018
39
0.210
Why?
Sexual and Gender Minorities
1
2023
28
0.210
Why?
Vaginosis, Bacterial
2
2019
19
0.210
Why?
Treatment Outcome
3
2020
867
0.210
Why?
Communicable Disease Control
1
2023
101
0.210
Why?
Enzyme Replacement Therapy
1
2022
2
0.200
Why?
Glucosylceramidase
1
2022
3
0.200
Why?
Gaucher Disease
1
2022
4
0.200
Why?
Vagina
2
2019
91
0.200
Why?
Acquired Immunodeficiency Syndrome
1
2023
186
0.190
Why?
Health Services Research
1
2021
57
0.190
Why?
Immunity, Innate
1
2021
10
0.190
Why?
Patient Acceptance of Health Care
2
2015
235
0.190
Why?
Pandemics
1
2023
280
0.190
Why?
Culture
2
2011
21
0.180
Why?
B-Lymphocytes
1
2020
33
0.180
Why?
Qualitative Research
3
2012
294
0.180
Why?
Socioeconomic Factors
5
2015
405
0.180
Why?
Gene Expression Profiling
1
2020
41
0.180
Why?
HIV
3
2022
380
0.180
Why?
Injection Site Reaction
1
2020
3
0.180
Why?
Reminder Systems
1
2020
8
0.180
Why?
Health Knowledge, Attitudes, Practice
3
2012
247
0.180
Why?
Arthralgia
1
2020
4
0.180
Why?
Headache
1
2020
7
0.180
Why?
Injections, Intramuscular
1
2020
30
0.180
Why?
Sex Factors
1
2021
224
0.180
Why?
Interleukin-15
1
2019
1
0.170
Why?
Contraception
2
2011
90
0.170
Why?
Administration, Intravaginal
1
2019
50
0.170
Why?
Lactobacillus
1
2019
7
0.170
Why?
Probiotics
1
2019
12
0.170
Why?
Survival Rate
1
2019
96
0.170
Why?
Killer Cells, Natural
1
2019
50
0.170
Why?
Randomized Controlled Trials as Topic
1
2020
237
0.170
Why?
Virion
1
2019
12
0.170
Why?
Biomedical Research
1
2019
48
0.170
Why?
Vaccines, DNA
2
2016
10
0.170
Why?
Vaginal Smears
1
2019
34
0.160
Why?
HIV Antigens
4
2021
26
0.160
Why?
Reproductive Tract Infections
1
2018
8
0.160
Why?
Cross-Sectional Studies
5
2017
1377
0.150
Why?
Surveys and Questionnaires
3
2019
532
0.150
Why?
Antibodies, Viral
1
2020
266
0.150
Why?
Adolescent Behavior
2
2015
58
0.150
Why?
Pregnancy
4
2012
1815
0.150
Why?
Risk-Taking
4
2020
119
0.150
Why?
Sexually Transmitted Diseases
1
2018
101
0.150
Why?
Immunity, Humoral
4
2019
42
0.150
Why?
Pleural Cavity
1
2017
7
0.140
Why?
Radiography
1
2017
80
0.140
Why?
Genital Diseases, Male
1
2016
8
0.140
Why?
Foreskin
1
2016
10
0.140
Why?
Penis
1
2016
8
0.140
Why?
Sexual Partners
3
2015
211
0.130
Why?
Tuberculosis Vaccines
1
2015
8
0.130
Why?
AIDS-Related Opportunistic Infections
1
2017
194
0.120
Why?
Interviews as Topic
3
2011
190
0.120
Why?
Coinfection
1
2017
268
0.120
Why?
Violence
1
2015
68
0.120
Why?
Protein Precursors
1
2014
22
0.120
Why?
Poverty
1
2015
149
0.120
Why?
Reproductive Health Services
1
2015
66
0.110
Why?
Immune Tolerance
1
2013
22
0.110
Why?
Tuberculosis, Pulmonary
1
2017
320
0.110
Why?
Patient Compliance
2
2011
120
0.110
Why?
Floxacillin
1
2013
6
0.110
Why?
Surgical Wound Infection
1
2013
13
0.110
Why?
Primary Health Care
1
2015
228
0.110
Why?
Risk Assessment
3
2020
217
0.110
Why?
Health Services Accessibility
2
2012
265
0.100
Why?
Prejudice
1
2012
8
0.100
Why?
Maternal Health Services
1
2012
51
0.100
Why?
Canarypox virus
2
2021
4
0.090
Why?
Africa South of the Sahara
3
2021
328
0.090
Why?
Treatment Failure
3
2021
175
0.090
Why?
Reproductive Behavior
1
2010
3
0.090
Why?
Cohort Studies
3
2019
939
0.090
Why?
Amenorrhea
1
2010
9
0.090
Why?
Vaccines, Synthetic
2
2024
7
0.090
Why?
Viremia
1
2010
66
0.090
Why?
Treatment Refusal
1
2010
13
0.090
Why?
Contraceptive Agents, Female
1
2010
47
0.080
Why?
Women's Health
1
2009
41
0.080
Why?
Safe Sex
2
2019
67
0.080
Why?
Ambulatory Care Facilities
2
2020
125
0.080
Why?
Papillomaviridae
1
2008
33
0.080
Why?
Drug Resistance, Viral
1
2010
268
0.080
Why?
DNA, Viral
1
2008
165
0.070
Why?
Risk
2
2021
87
0.070
Why?
Papillomavirus Infections
1
2008
72
0.070
Why?
Interferon-gamma
2
2019
39
0.070
Why?
CD4 Lymphocyte Count
3
2017
654
0.070
Why?
Infant, Newborn
1
2012
1410
0.070
Why?
Immunity, Cellular
2
2018
25
0.070
Why?
Prospective Studies
2
2019
1131
0.060
Why?
Genotype
2
2022
430
0.060
Why?
Substance-Related Disorders
2
2015
49
0.060
Why?
Viral Vaccines
1
2024
21
0.060
Why?
Proportional Hazards Models
2
2015
163
0.060
Why?
Vaccines, Combined
1
2024
34
0.060
Why?
Immunoglobulin A
1
2024
39
0.060
Why?
Child
2
2022
2180
0.050
Why?
Disease Progression
2
2017
154
0.050
Why?
Infant
2
2022
2145
0.050
Why?
Homosexuality, Male
1
2023
48
0.050
Why?
Demography
2
2014
105
0.050
Why?
Community Participation
1
2022
42
0.050
Why?
Multivariate Analysis
2
2014
171
0.050
Why?
Splenectomy
1
2022
3
0.050
Why?
Thrombocytopenia
1
2022
11
0.050
Why?
Anemia
1
2022
41
0.050
Why?
Registries
1
2022
89
0.050
Why?
Americas
1
2021
10
0.050
Why?
Proof of Concept Study
1
2021
13
0.050
Why?
Europe
1
2021
53
0.050
Why?
Leukocytes, Mononuclear
1
2021
60
0.050
Why?
Vaccinia virus
1
2020
2
0.050
Why?
Receptors, Antigen, B-Cell
1
2020
6
0.050
Why?
Half-Life
1
2020
21
0.050
Why?
Longitudinal Studies
1
2022
409
0.050
Why?
Lymphocyte Activation
1
2020
40
0.050
Why?
Gene Expression Regulation
1
2020
40
0.050
Why?
Linear Models
1
2020
82
0.040
Why?
Signal Transduction
1
2020
33
0.040
Why?
Plasmids
1
2020
23
0.040
Why?
Retrospective Studies
2
2013
767
0.040
Why?
DNA
1
2020
73
0.040
Why?
Granzymes
1
2019
1
0.040
Why?
Text Messaging
1
2020
25
0.040
Why?
Antibody Specificity
1
2020
30
0.040
Why?
Cefixime
1
2019
2
0.040
Why?
Doxycycline
1
2019
3
0.040
Why?
Metronidazole
1
2019
4
0.040
Why?
CD40 Ligand
1
2019
4
0.040
Why?
Thailand
1
2019
24
0.040
Why?
Interleukin-2
1
2019
22
0.040
Why?
Phagocytosis
1
2019
15
0.040
Why?
Principal Component Analysis
1
2019
20
0.040
Why?
Placebos
1
2019
44
0.040
Why?
Glycogen
1
2019
3
0.040
Why?
Epitopes
1
2020
97
0.040
Why?
Coitus
1
2019
15
0.040
Why?
Viral Load
2
2016
808
0.040
Why?
T-Lymphocytes
1
2019
59
0.040
Why?
Neutralization Tests
1
2019
106
0.040
Why?
Unsafe Sex
1
2019
45
0.040
Why?
Pilot Projects
1
2019
168
0.040
Why?
Trichomonas Vaginitis
1
2018
4
0.040
Why?
Trichomonas Infections
1
2018
5
0.040
Why?
Herpes Simplex
1
2018
7
0.040
Why?
Syphilis
1
2018
14
0.040
Why?
Chlamydia Infections
1
2018
17
0.040
Why?
Gonorrhea
1
2018
20
0.040
Why?
Candidiasis
1
2018
15
0.040
Why?
Dizziness
1
2018
2
0.040
Why?
Back Pain
1
2018
4
0.040
Why?
Macaca mulatta
1
2018
14
0.040
Why?
Aspartate Aminotransferases
1
2018
10
0.040
Why?
Abdominal Pain
1
2018
7
0.040
Why?
Africa, Southern
1
2018
89
0.040
Why?
Fatigue
1
2018
20
0.040
Why?
Dose-Response Relationship, Drug
1
2018
124
0.040
Why?
Feasibility Studies
1
2018
95
0.040
Why?
Data Collection
1
2018
86
0.040
Why?
Diarrhea
1
2018
76
0.040
Why?
Aged
1
2022
1650
0.040
Why?
Child, Preschool
1
2022
1675
0.040
Why?
Antibiotics, Antitubercular
1
2017
47
0.030
Why?
Predictive Value of Tests
1
2017
183
0.030
Why?
tat Gene Products, Human Immunodeficiency Virus
1
2016
2
0.030
Why?
Anti-Infective Agents, Local
1
2016
16
0.030
Why?
Africa, Eastern
1
2016
16
0.030
Why?
Pediatrics
1
2016
16
0.030
Why?
United States
1
2016
129
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2016
150
0.030
Why?
Acyltransferases
1
2015
4
0.030
Why?
Dose-Response Relationship, Immunologic
1
2015
11
0.030
Why?
BCG Vaccine
1
2015
20
0.030
Why?
Antigens, Bacterial
1
2015
32
0.030
Why?
CD8-Positive T-Lymphocytes
1
2015
43
0.030
Why?
Animals
1
2018
1063
0.030
Why?
Sex Offenses
1
2015
29
0.030
Why?
Enzyme-Linked Immunospot Assay
1
2014
10
0.030
Why?
Antibodies, Bacterial
1
2015
149
0.030
Why?
Depression
1
2015
117
0.030
Why?
Administration, Oral
1
2013
113
0.030
Why?
Cross-Cultural Comparison
1
2011
16
0.020
Why?
Brazil
1
2011
43
0.020
Why?
Kaplan-Meier Estimate
1
2011
103
0.020
Why?
Epidemiologic Methods
1
2010
25
0.020
Why?
Kenya
1
2011
173
0.020
Why?
Logistic Models
1
2010
252
0.020
Why?
Tuberculosis
1
2015
530
0.020
Why?
Prevalence
1
2010
1149
0.020
Why?
Laher's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (268)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_